title: [Danazol treatment of hereditary angioneurotic oedema (author's transl)].
abstract: Danazol, an attenuated androgen, was administered to four patients with hereditary angioneurotic oedema, with rapid and complete response without side-effects. The follow-up period has now been up to 17 months. In all patients there was an indirect indication that their hormonal state influenced the course of the disease.
mesh_terms: D000328:Adult; D000799:Angioedema / Q000188:drug therapy* / Q000235:genetics; D002648:Child; D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011245:Pregnadienes / Q000627:therapeutic use*
chemical_list: D011245:Pregnadienes; D003613:Danazol
vernacular_title: Danazoltherapie des hereditären Angioödems.